Search

Your search keyword '"Arooj Akhtar"' showing total 5 results
Start Over Author "Arooj Akhtar"
5 results on '"Arooj Akhtar"'

1. Supplementary Figure 1 from Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer

Author

Tiffany A. Traina, Clifford A. Hudis, Kimberly N. Feigin, Sujata Patil, Dilip D. Giri, Arooj Akhtar, Joseph M. Gonzalez, Lamia F. Momen, Mary Ellen Moynahan, Michael Danso, Ashley S. Doane, Vered Stearns, Andres Forero, Lisle Nabell, Hope Rugo, Kimberly Blackwell, Lisa A. Carey, Minetta C. Liu, James N. Ingle, Steven J. Isakoff, Sara Tolaney, and Ayca Gucalp

Abstract

Supplementary Figure 1 - PDF file 44K, Supplementary Figure 1A-D. Median hormone levels at baseline, C2 and EOS

Published
2023

2. Supplementary Legend from Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer

Author

Tiffany A. Traina, Clifford A. Hudis, Kimberly N. Feigin, Sujata Patil, Dilip D. Giri, Arooj Akhtar, Joseph M. Gonzalez, Lamia F. Momen, Mary Ellen Moynahan, Michael Danso, Ashley S. Doane, Vered Stearns, Andres Forero, Lisle Nabell, Hope Rugo, Kimberly Blackwell, Lisa A. Carey, Minetta C. Liu, James N. Ingle, Steven J. Isakoff, Sara Tolaney, and Ayca Gucalp

Abstract

Supplementary Legend - PDF file 22K, Supplementary Legend

Published
2023

3. Supplementary Figure 2 from Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer

Author

Tiffany A. Traina, Clifford A. Hudis, Kimberly N. Feigin, Sujata Patil, Dilip D. Giri, Arooj Akhtar, Joseph M. Gonzalez, Lamia F. Momen, Mary Ellen Moynahan, Michael Danso, Ashley S. Doane, Vered Stearns, Andres Forero, Lisle Nabell, Hope Rugo, Kimberly Blackwell, Lisa A. Carey, Minetta C. Liu, James N. Ingle, Steven J. Isakoff, Sara Tolaney, and Ayca Gucalp

Abstract

Supplementary Figure 2 - PDF file 275K, Supplementary Figure 2A-D. Changes in hormone levels over time per patient; responders (stable disease >6 months) highlighted in red

Published
2023

4. Supplementary Table 1 from Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer

Author

Tiffany A. Traina, Clifford A. Hudis, Kimberly N. Feigin, Sujata Patil, Dilip D. Giri, Arooj Akhtar, Joseph M. Gonzalez, Lamia F. Momen, Mary Ellen Moynahan, Michael Danso, Ashley S. Doane, Vered Stearns, Andres Forero, Lisle Nabell, Hope Rugo, Kimberly Blackwell, Lisa A. Carey, Minetta C. Liu, James N. Ingle, Steven J. Isakoff, Sara Tolaney, and Ayca Gucalp

Abstract

Supplementary Table 1 - PDF file 4K, Supplementary Table 1. Median hormone levels at baseline, start of cycle 2 (C2), and end of study (EOS) and the percent change in levels from baseline to C2 and C2 to EOS

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results